Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
40.10
-0.80 (-1.96%)
Apr 29, 2026, 1:58 PM CST
TPEX:7427 Market Cap
TPEX:7427 has a market cap or net worth of 1.72 billion as of April 29, 2026. Its market cap has decreased by -6.04% in one year.
Market Cap
1.72B
Enterprise Value
1.28B
Revenue
1.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.10
Market Cap Chart
Since July 8, 2021, TPEX:7427's market cap has increased from 1.48B to 1.72B, an increase of 16.48%. That is a compound annual growth rate of 3.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 1.72B | 25.31% |
| Dec 31, 2025 | 1.37B | -7.37% |
| Dec 31, 2024 | 1.48B | -42.09% |
| Dec 29, 2023 | 2.56B | 40.55% |
| Dec 30, 2022 | 1.82B | 94.83% |
| Dec 30, 2021 | 935.73M | -36.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anti-Microbial Savior BioteQ | 1.98B |
| Synbio Tech | 1.99B |
| Bio Preventive Medicine | 1.69B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.07B |
| TaiRx | 2.08B |
| Genomics BioSci & Tech. | 2.12B |
| Sunny Pharmtech | 2.14B |
| Chunghwa Chemical Synthesis & Biotech | 2.15B |